Common Contracts
5 similar null contracts by Olema Pharmaceuticals, Inc.
November 13, 2020Olema Pharmaceuticals, Inc. • November 16th, 2020 • Pharmaceutical preparations
As you know, you are currently employed by Olema Pharmaceuticals, Inc. (the “Company”) as its Chief Development Officer, pursuant to the terms of an offer letter from the Company dated June 15, 2020 (the “Offer Letter”). In connection with your continuing employment, you and the Company are hereby agreeing to the amended terms of employment set forth herein. The terms set forth in this offer letter (“Agreement”) amend, restate, supersede and replace the terms set forth in the Offer Letter in their entirety.
November 13, 2020Olema Pharmaceuticals, Inc. • November 16th, 2020 • Pharmaceutical preparations
As you know, you are currently employed by Olema Pharmaceuticals, Inc. (the “Company”) as its Chief Business Officer, pursuant to the terms of an offer letter from the Company dated May 14, 2020 (the “Offer Letter”). In connection with your continuing employment, you and the Company are hereby agreeing to the amended terms of employment set forth herein. The terms set forth in this offer letter (“Agreement”) amend, restate, supersede and replace the terms set forth in the Offer Letter in their entirety.
VIA EMAILOlema Pharmaceuticals, Inc. • November 16th, 2020 • Pharmaceutical preparations
As you know, you are currently employed by Olema Pharmaceuticals, Inc. (the “Company”) as its Chief Financial Officer and Chief Operating Officer, pursuant to the terms of an offer letter from the Company dated June 15, 2020 (the “Offer Letter”). In connection with your continuing employment, you and the Company are hereby agreeing to the amended terms of employment set forth herein. The terms set forth in this offer letter (“Agreement”) amend, restate, supersede and replace the terms set forth in the Offer Letter in their entirety.
November 13, 2020Olema Pharmaceuticals, Inc. • November 16th, 2020 • Pharmaceutical preparations
As you know, you are currently employed by Olema Pharmaceuticals, Inc. (the “Company”) as its Chief Technology Officer, pursuant to the terms of an offer letter from the Company dated June 15, 2020 (the “Offer Letter”). In connection with your continuing employment, you and the Company are hereby agreeing to the amended terms of employment set forth herein. The terms set forth in this offer letter (“Agreement”) amend, restate, supersede and replace the terms set forth in the Offer Letter in their entirety.
November 13, 2020Olema Pharmaceuticals, Inc. • November 16th, 2020 • Pharmaceutical preparations
As you know, you are currently employed by Olema Pharmaceuticals, Inc. (the “Company”) as its Chief Scientific Officer, pursuant to the terms of an offer letter from the Company dated June 15, 2020 (the “Offer Letter”). In connection with your continuing employment, you and the Company are hereby agreeing to the amended terms of employment set forth herein. The terms set forth in this offer letter (“Agreement”) amend, restate, supersede and replace the terms set forth in the Offer Letter in their entirety.
